Leah Bennett of Concurrent told Reuters drug companies raised over $50 billion of new investment in 2020, and they've used it ...

Michael Yee, global head of biotech research at UBS, joins CNBC’s ‘Squawk on the Street’ to explain Moderna's narrower-than-expected loss, why healthcare is outperforming, and vaccine mandates and ...

At WHX 2026 Dubai, Andrew Craig, author of Our Future Is Biotech, outlines why he believes this century will be defined not by physics and technology, but by ...

This was a very rapid 48-hour massacre,” the head of an advocacy group tracking the victims of government violence said.

Jay Woods of Freedom Capital Markets explains why tech is digesting gains after years of outperformance.

Colossal Laboratories & Biosciences, which has produced a trio of modern-day dire wolves and the woolly mouse, seeks to bring back extinct species.

After a long period of stalled dealmaking, M&A sentiment is now at a six-year high. Citizens Head of Commercial Banking Ted Swimmer joins Market Catalysts host Julie Hyman to share which sectors are ...

The United Nations designated 21 April as World Creativity and Innovation Day to raise awareness of the role of creativity ...

Publishing firm COL Group Co. surged to its 20% daily upper trading limit, while Shanghai Film Co. and gaming and ...

Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 ...

Outsourcing is driving biopharma efficiency and scale, including in the drug discovery area and early phase development. Forming strategic partne ...